LifeMD, Inc. - Preferred Stock - Laporan Laba Rugi (TTM)

LifeMD, Inc. - Preferred Stock

Laporan Laba Rugi (TTM)

Laporan Laba Rugi LifeMD, Inc. - Preferred Stock menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 28 37 51 64 78 93 104 112 118 119 123 129 136 153 164 178 193 212 234 246
Change (%) 31.57 37.25 25.83 21.64 18.54 11.68 7.85 5.78 0.59 3.43 4.46 5.60 12.33 7.22 9.00 8.29 10.05 10.15 4.94
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 5 9 11 13 16 18 20 21 20 19 18 18 18 19 19 20 20 24 28 31
Change (%) 63.06 21.14 20.60 26.43 9.95 11.32 2.57 -1.85 -7.44 -5.53 -0.49 0.37 7.31 2.04 2.47 1.17 20.38 16.80 8.56
% of Revenue 19.17 23.76 20.97 20.10 20.89 19.38 19.31 18.37 17.04 15.68 14.32 13.64 12.97 12.39 11.79 11.08 10.36 11.33 12.01 12.43
Gross Operating Profit 23 28 40 51 62 75 84 91 98 100 105 111 118 134 144 159 173 188 206 215
Change (%) 24.10 42.27 27.22 20.44 20.80 11.76 9.12 7.50 2.24 5.10 5.29 6.43 13.07 7.96 9.87 9.18 8.85 9.29 4.44
% of Revenue 80.83 76.24 79.03 79.90 79.11 80.62 80.69 81.63 82.96 84.32 85.68 86.36 87.03 87.61 88.21 88.92 89.64 88.67 87.99 87.57
SG&A 48 85 106 129 131 125 134 137 136 131 125 123 128 137 149 163 176 187 195 198
Change (%) 77.12 25.32 21.80 1.43 -4.74 7.28 2.10 -0.67 -3.47 -4.54 -2.06 3.93 7.15 9.12 9.43 8.05 6.13 4.37 1.26
% of Revenue 168.79 227.22 207.46 200.80 167.43 134.55 129.25 122.35 114.89 110.25 101.75 95.40 93.90 89.57 91.15 91.52 91.31 88.07 83.45 80.53
R&D 0 0 1 1 1 1 1 2 2 3 4 4 5 6 7 8 9 10 10 10
Change (%) 26.22 52.14 4.45 1.38 31.74 12.37 54.29 42.19 27.07 25.43 18.24 15.36 19.26 14.91 14.67 13.94 4.53 6.18 3.38
% of Revenue 1.25 1.20 1.33 1.10 0.92 1.02 1.03 1.47 1.98 2.50 3.03 3.43 3.74 3.97 4.26 4.48 4.71 4.48 4.32 4.25
OpEx 54 95 119 145 151 147 159 164 165 159 153 150 155 167 181 197 212 229 241 248
Change (%) 74.98 25.31 21.93 4.13 -2.74 8.18 3.09 0.42 -3.70 -3.89 -1.65 3.30 7.78 8.58 8.89 7.54 7.63 5.62 2.55
% of Revenue 191.77 255.04 232.84 225.61 193.12 158.47 153.50 146.72 139.29 133.34 123.91 116.66 114.12 109.50 110.89 110.78 110.01 107.60 103.18 100.83
Operating Income -26 -58 -68 -81 -73 -54 -55 -52 -46 -40 -29 -21 -19 -14 -18 -19 -19 -16 -7 -2
Change (%) 122.29 17.60 18.98 -9.82 -25.58 2.19 -5.81 -11.05 -14.64 -25.84 -27.21 -10.49 -24.44 22.90 7.92 0.61 -16.50 -53.98 -72.66
% of Revenue -91.77 -155.04 -132.84 -125.61 -93.12 -58.47 -53.50 -46.72 -39.29 -33.34 -23.91 -16.66 -14.12 -9.50 -10.89 -10.78 -10.01 -7.60 -3.18 -0.83
Interest Expense -2 -2 -1 -2 -3 -3 -3 -2 -1 -1 -1 -2 -3 -3 -3 -2 -2 -2 -2 -2
Change (%) 1.48 -39.19 66.38 90.91 -6.24 0.94 -25.25 -74.28 117.75 7.57 62.91 26.01 -7.84 8.21 -16.52 -6.62 -0.39 6.81 5.65
% of Revenue -5.80 -4.47 -1.98 -2.62 -4.11 -3.25 -2.94 -2.04 -0.50 -1.07 -1.11 -1.74 -2.07 -1.70 -1.72 -1.32 -1.13 -1.03 -1.00 -1.00
Net Income -27 -59 -68 -81 -75 -61 -63 -59 -52 -46 -36 -30 -29 -21 -23 -23 -23 -19 -11 -6
Change (%) 116.35 15.70 19.82 -7.71 -18.84 2.79 -6.09 -12.03 -11.94 -20.40 -17.34 -3.87 -28.48 13.40 0.61 -4.22 -16.11 -43.18 -44.75
% of Revenue -95.64 -157.26 -132.56 -126.23 -95.77 -65.57 -60.35 -52.55 -43.70 -38.25 -29.44 -23.29 -21.21 -13.50 -14.28 -13.18 -11.66 -8.89 -4.58 -2.41

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista